[New] Focal therapy can provide durable cancer control for selected patients while reducing risks such as urinary leakage and sexual dysfunction compared with radical treatment.
LucidQuest Ventures
As the Parker Institute for Cancer Immunotherapy marks its 10th anniversary, Immuno 2026 will highlight a decade of progress in collaborative cancer immunotherapy research while looking ahead to the next generation of immune-based cancer treatments.
Oncodaily - Oncology News, Insights, Stories
Last updated: 20 September 2026
Hi,
Would you like a quick online demo of our service from an experienced member of our team?
